Navigation Links
International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor
Date:6/17/2013

Lenexa, KS (PRWEB) June 18, 2013

Essential tremor (ET) is the most common of all movements disorders, affecting an estimated 10 million people in the United States, and millions more worldwide. At this time there is no clear understanding what causes ET, there are no medications specifically designed to treat it and there is no cure. Tulips for Tremor© is the International Essential Tremor Foundation’s annual research fundraiser, supporting research into the causes of and a cure for this life-altering neurological condition.

“Although millions are affected, little is understood about this condition,” explains Catherine Rice, executive director of the International Essential Tremor Foundation. “Anyone at any age can develop essential tremor, but it is still unclear what causes it. It is vital to fund research that will shed light on this dilemma, allowing for better treatment options and diagnostic tools in the future.”

Donations to Tulips for Tremor© will support IETF research grants. In 2013, the IETF awarded $85,000 in essential tremor research grants for projects in assistive robotics, brain tissue analysis and childhood presentation.

Essential tremor is a neurological condition that causes a rhythmic shaking of the hands, head, voice, legs or trunk. It is often misdiagnosed as Parkinson’s disease, although eight times more common. Because of stereotypes and a lack of awareness, many people with ET never seek medical care though most would benefit from treatment.

For more information and to donate, visit the IETF at http://www.essentialtremor.org/tulips-for-tremor.

About The International Essential Tremor Foundation:
Headquartered in Lenexa, KS, and founded in 1988, the International Essential Tremor Foundation is the leading organization in the world dedicated to those affected by essential tremor. The mission of the IETF is to fund research that will find the cause of essential tremor and lead to better treatments and a cure, increase awareness about ET, and provide educational materials, tools and support to healthcare providers, the public, and those directly affected by ET.

The IETF has distributed more than $685,000 in research grants, to fund 27 promising studies, in the search for the cause of ET. The Foundation has hosted numerous community awareness events across the U.S. to provide those affected with the basic knowledge necessary to become their own advocate when seeking treatment. And, the IETF also provides assistance to a vast network of support groups around the world. To learn more about essential tremor and the IETF mission, visit the IETF website at http://www.essentialtremor.org.

For comment or interview:
Catherine Rice, IETF Executive Director
913.341.3880
crice(at)essentialtremor(dot)org

###

Read the full story at http://www.prweb.com/releases/2013/6/prweb10823355.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. International Yoga Training School Launches At-Home Version of Hot Yoga
2. Guinness International Champions Cup Ticket Prices Slashed for Matches Featuring Real Madrid, Juventus, LA Galaxy, Everton, Inter Milan, Chelsea FC, AC Milan & Valencia
3. Migraine and headache specialists gather at international headache congress scientific sessions
4. 2013 BioProcess Theater Presentations Now Available on the BioProcess International Digital Media Website
5. National Daylight Appreciation Day and Solatube International Celebrate the Benefits of Sunlight on the Longest Day of the Year
6. Platinum Supplemental Insurance Sponsors Julien Dubuque International Film Fest
7. Robert Clemente, Jr. Joins Nutritional Products International Board of Directors
8. foru International Appoints New Chief Marketing Officer
9. Glidewell International Technology Center Announces a Surgical Hands-on Course on Small-Diameter Dental Implants
10. MDS 17th International Congress of Parkinson’s Disease and Movement Disorders
11. The International Essential Tremor Foundation Funds Ground-Breaking Essential Tremor Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is ... 11th, 2016 in honor of his birthday on February 10th. During this time, ... Trivedi is known by over 250,000 people from over 40 different countries as an ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by the ... dental technicians to be certified or obtain continuing education. To increase patient awareness ... In Your Mouth?” campaign to inform dentists and patients about the possible lack ...
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... women on Friday in recognition of National Wear Red Day. National Wear Red ... heart disease and stroke in women. Heart disease and stroke cause 1 in 3 ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... 2016 , ... US Sports Camps is proud to sponsor the Bay Area ... top non-profit leaders, ultimate organizations, and coaches from around the US. The theme for ... Program Director of Youth and Education, describes this year YUCC as “an important conversation ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016 ... the addition of the "Label-Free Detection ... Forecasts to 2020" report to their ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ...
(Date:2/8/2016)... , Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced that it will ... ended December 31, 2015 after market close on February 9, ... conference call to discuss these financial results.    ... --> About Unilife Corporation ...
(Date:2/8/2016)... 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced that the U.S. Food and Drug Administration ... (IND) application for SB-318, a single treatment strategy ... Type I (MPS I). The SB-318 IND application ... a Phase 1/2 clinical study (SB-318-1502) designed to ...
Breaking Medicine Technology: